Financhill
Sell
38

BAC Quote, Financials, Valuation and Earnings

Last price:
$43.81
Seasonality move :
8.37%
Day range:
$43.10 - $44.40
52-week range:
$31.27 - $48.08
Dividend yield:
2.26%
P/E ratio:
16.06x
P/S ratio:
3.57x
P/B ratio:
1.25x
Volume:
72.8M
Avg. volume:
35.4M
1-year change:
33.93%
Market cap:
$338.9B
Revenue:
$98.6B
EPS (TTM):
$2.75
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $91.2B $85.5B $89.1B $95B $98.6B
Revenue Growth (YoY) 0.25% -6.27% 4.19% 6.55% 3.82%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $42.1B $41.2B $45B $45.9B $47.7B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $42.1B $41.2B $45B $45.9B $45.6B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $32.8B $19B $34B $31B $28.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $5.3B $1.1B $2B $3.4B $1.8B
Net Income to Company $27.4B $17.9B $32B $27.5B $26.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $27.4B $17.9B $32B $27.5B $26.5B
 
Basic EPS (Cont. Ops) $2.77 $1.88 $3.60 $3.21 $3.10
Diluted EPS (Cont. Ops) $2.75 $1.87 $3.57 $3.19 $3.08
Weighted Average Basic Share $9.4B $8.8B $8.5B $8.1B $8B
Weighted Average Diluted Share $9.4B $8.8B $8.6B $8.2B $8.1B
 
EBITDA -- -- -- -- --
EBIT $55.1B $27.2B $38.7B $51.1B $101.7B
 
Revenue (Reported) $91.2B $85.5B $89.1B $95B $98.6B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $55.1B $27.2B $38.7B $51.1B $101.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $20.3B $22.8B $24.5B $25.2B $25.3B
Revenue Growth (YoY) -10.83% 11.95% 7.63% 2.71% 0.71%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $10.8B $10.8B $11.5B $11.8B $12.1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $10.8B $10.8B $11.5B $11.8B $12.1B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $4.5B $9B $8.3B $8.1B $7.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$335M $1.3B $1.2B $293M $428M
Net Income to Company $4.9B $7.7B $7.1B $7.8B $6.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.9B $7.7B $7.1B $7.8B $6.9B
 
Basic EPS (Cont. Ops) $0.51 $0.86 $0.81 $0.91 $0.82
Diluted EPS (Cont. Ops) $0.51 $0.85 $0.81 $0.90 $0.81
Weighted Average Basic Share $8.7B $8.4B $8.1B $8B $7.8B
Weighted Average Diluted Share $8.8B $8.5B $8.2B $8.1B $7.9B
 
EBITDA -- -- -- -- --
EBIT $5.9B $10.2B $14.2B $27.3B $30.8B
 
Revenue (Reported) $20.3B $22.8B $24.5B $25.2B $25.3B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $5.9B $10.2B $14.2B $27.3B $30.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $87.8B $87.2B $92.5B $101.2B $98.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $40.9B $44.3B $45.5B $47.6B $49.6B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $40.9B $44.3B $45.5B $47.6B $50.3B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $21B $32.3B $30.9B $33.1B $25.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.6B $1.8B $3.5B $2.6B $1.7B
Net Income to Company $19.4B $30.4B $27.4B $30.5B $23.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $19.4B $30.4B $27.4B $30.5B $23.6B
 
Basic EPS (Cont. Ops) $2.04 $3.37 $3.17 $3.59 $2.78
Diluted EPS (Cont. Ops) $2.02 $3.33 $3.16 $3.57 $2.75
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT $32.8B $37.1B $41.7B $95.2B $115.9B
 
Revenue (Reported) $87.8B $87.2B $92.5B $101.2B $98.5B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $32.8B $37.1B $41.7B $95.2B $115.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $65.4B $67.1B $70.4B $76.6B $76.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $31B $34.1B $34.5B $36.1B $38B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $31B $34.1B $34.5B $36.1B $38.7B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $12.9B $26.2B $23.1B $25.2B $22.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $452M $1.2B $2.7B $1.8B $1.7B
Net Income to Company $12.4B $25B $20.4B $23.4B $20.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $12.4B $25B $20.4B $23.4B $20.5B
 
Basic EPS (Cont. Ops) $1.29 $2.77 $2.35 $2.74 $2.42
Diluted EPS (Cont. Ops) $1.28 $2.74 $2.34 $2.72 $2.40
Weighted Average Basic Share $26.3B $25.8B $24.4B $24.1B $23.7B
Weighted Average Diluted Share $26.4B $26B $24.5B $24.3B $23.9B
 
EBITDA -- -- -- -- --
EBIT $19.9B $29.8B $32.8B $76.9B $91.1B
 
Revenue (Reported) $65.4B $67.1B $70.4B $76.6B $76.5B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $19.9B $29.8B $32.8B $76.9B $91.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $168.7B $387B $355.4B $237.5B $341.4B
Short Term Investments $245.6B $234.5B $299.2B $220.8B $266.6B
Accounts Receivable, Net $55.9B $64.2B $72.3B $67.5B $81.9B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $805B $1.1T $1T $855.6B $1T
 
Property Plant And Equipment $10.6B $11B $10.8B $11.5B $11.9B
Long-Term Investments $611.1B $792.2B $1.1T $1T $1T
Goodwill $69B $69B $69B $69B $69B
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $2.4T $2.8T $3.2T $3.1T $3.2T
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $24.2B $19.3B $23.8B $26.9B $32.1B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $189.3B $189.6B $216.1B $222.6B $316B
 
Long-Term Debt $240.9B $262.9B $280.1B $276B $302.2B
Capital Leases -- -- -- -- --
Total Liabilities $2.2T $2.5T $2.9T $2.8T $2.9T
 
Common Stock $115.1B $110.5B $87.1B $87.4B $84.8B
Other Common Equity Adj -$6.6B -$1.7B -$5.1B -$21.2B -$17.8B
Common Equity $241.4B $248.4B $245.4B $244.8B $263.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $264.8B $272.9B $270.1B $273.2B $291.6B
 
Total Liabilities and Equity $2.4T $2.8T $3.2T $3.1T $3.2T
Cash and Short Terms $414.3B $621.5B $654.5B $458.3B $608.1B
Total Debt $265.1B $282.3B $303.9B $302.9B $334.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $306.1B $286.4B $212.4B $359.7B $303.7B
Short Term Investments $233.7B $275.4B $226.3B $165.6B $315.7B
Accounts Receivable, Net $61.7B $75B $76.2B $74.3B $91.3B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $989.8B $954.5B $875.1B $970.3B $1.1T
 
Property Plant And Equipment $10.9B $10.7B $11.1B $11.8B $12B
Long-Term Investments $729.2B $1.1T $1.1T $930.6B $1.1T
Goodwill $69B $69B $69B $69B $69B
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $2.7T $3.1T $3.1T $3.2T $3.3T
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $17.9B $20.3B $21B $40.2B $38.4B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $208.6B $227.7B $236.7B $340.9B $436.4B
 
Long-Term Debt $255.7B $278.6B $269.1B $290.4B $296.9B
Capital Leases -- -- -- -- --
Total Liabilities $2.5T $2.8T $2.8T $2.9T $3T
 
Common Stock $109.4B $93.1B $88.6B $85.1B $72.9B
Other Common Equity Adj -$978M -$3.6B -$21B -$21.8B -$14.3B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- -$2B
Minority Interest, Total -- -- -- -- --
Total Equity $268.9B $272.5B $269.5B $287.1B $296.5B
 
Total Liabilities and Equity $2.7T $3.1T $3.1T $3.2T $3.3T
Cash and Short Terms $539.8B $561.7B $438.8B $525.3B $619.5B
Total Debt $273.6B $298.9B $290.2B $330.6B $335.4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $27.4B $17.9B $32B $27.5B $26.5B
Depreciation & Amoritzation $1.7B $1.8B $1.9B $2B $2.1B
Stock-Based Compensation $2B $2B $2.8B $2.9B $2.9B
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $61.8B $38B -$7.2B -$6.3B $45B
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$80.6B -$177.7B -$313.3B -$2.5B -$35.4B
 
Dividends Paid (Ex Special Dividend) -$5.9B -$7.7B -$8.1B -$8.6B -$9.1B
Special Dividend Paid
Long-Term Debt Issued $52.4B $57B $76.7B $65.9B $65.4B
Long-Term Debt Repaid -$50.8B -$47.9B -$46.8B -$34.1B -$44.6B
Repurchase of Common Stock -$30.7B -$8.1B -$27.1B -$5.7B -$4.6B
Other Financing Activities -$698M -$601M -$620M -$312M -$717M
Cash From Financing $3.4B $355.8B $291.7B -$106B $93.3B
 
Beginning Cash (CF) $177.4B $161.6B $380.5B $348.2B $230.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$15.5B $216.1B -$28.8B -$114.9B $102.9B
Ending Cash (CF) $161.6B $380.5B $348.2B $230.2B $333.1B
 
Levered Free Cash Flow $61.8B $38B -$7.2B -$6.3B $45B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.9B $7.7B $7.1B $7.8B $6.9B
Depreciation & Amoritzation $476M $473M $491M $517M $549M
Stock-Based Compensation $520M $568M $704M $588M $832M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$32.6B $9.8B $13.2B $11.8B -$37.3B
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing $55B -$32.7B $34.8B -$59.9B -$27.3B
 
Dividends Paid (Ex Special Dividend) -$2B -$2.1B -$2.3B -$2.4B -$2.5B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $10.2B $17.3B $14.5B $22.2B $12.2B
Long-Term Debt Repaid -$16.2B -$9.5B -$8B -$9.9B -$16.6B
Repurchase of Common Stock -$114M -$9.9B -$450M -$1B -$5.5B
Other Financing Activities -$30M $41M $111M $45M $150M
Cash From Financing -$12.4B $43.7B -$37.9B $27.6B $36.8B
 
Beginning Cash (CF) $289.3B $260B $198B $373.6B $320.6B
Foreign Exchange Rate Adjustment $1.7B -$936M -$3.1B -$1.3B $2.7B
Additions / Reductions $9.9B $20.8B $10B -$20.5B -$27.8B
Ending Cash (CF) $301B $279.9B $205B $351.7B $295.6B
 
Levered Free Cash Flow -$32.6B $9.8B $13.2B $11.8B -$37.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $19.4B $30.4B $27.4B $30.5B $23.6B
Depreciation & Amoritzation $1.8B $1.9B $2B $2B $2.2B
Stock-Based Compensation $2.1B $2.5B $3B $2.8B $3.3B
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $42.5B $2.8B $7.3B $43.3B -$2B
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$167.1B -$308.3B -$75.8B $43.2B -$164.3B
 
Dividends Paid (Ex Special Dividend) -$7.7B -$7.9B -$8.4B -$9B -$9.5B
Special Dividend Paid
Long-Term Debt Issued $48.1B $81.6B $66.4B $63.7B $55B
Long-Term Debt Repaid -$45.1B -$49.6B -$32.4B -$41.8B -$65.1B
Repurchase of Common Stock -$15.8B -$19.8B -$11.6B -$5.4B -$14.2B
Other Financing Activities -$507M -$694M -$425M -$518M -$323M
Cash From Financing $266B $286.5B $1.4B $57.7B $108.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $141.5B -$19B -$67.1B $144.1B -$57.9B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $42.5B $2.8B $7.3B $43.3B -$2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $12.4B $25B $20.4B $23.4B $20.5B
Depreciation & Amoritzation $1.4B $1.4B $1.5B $1.5B $1.6B
Stock-Based Compensation $1.6B $2B $2.2B $2.2B $2.5B
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$16.6B -$51.8B -$37.3B $12.3B -$34.7B
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$123.8B -$254.4B -$16.9B $28.8B -$100.1B
 
Dividends Paid (Ex Special Dividend) -$5.9B -$6.1B -$6.5B -$6.9B -$7.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $40.9B $65.5B $55.2B $53B $42.6B
Long-Term Debt Repaid -$37.1B -$38.8B -$24.4B -$32.2B -$52.7B
Repurchase of Common Stock -$7.8B -$19.6B -$4.1B -$3.8B -$13.4B
Other Financing Activities -$603M -$696M -$501M -$707M -$313M
Cash From Financing $277.9B $208.6B -$81.7B $82.1B $97.1B
 
Beginning Cash (CF) $701.3B $966.6B $820.2B $980B $967.1B
Foreign Exchange Rate Adjustment $1.9B -$3B -$7.4B -$1.6B $201M
Additions / Reductions $137.5B -$97.6B -$135.9B $123.1B -$37.7B
Ending Cash (CF) $840.7B $866B $676.9B $1.1T $929.6B
 
Levered Free Cash Flow -$16.6B -$51.8B -$37.3B $12.3B -$34.7B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.55% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.29% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock